Company Filing History:
Years Active: 2021-2024
Title: Innovations of Yu Jin Shin in Neurological Treatments
Introduction
Yu Jin Shin, an accomplished inventor based in Gyeonggi-do, South Korea, has made significant contributions to the field of pharmaceuticals, particularly in the treatment of neurological diseases. With a total of five patents to his name, Shin's work revolves around innovative compounds that hold promise for improving patient outcomes.
Latest Patents
One of Yu Jin Shin's recent patents is focused on a compound having oxadiazole and pharmaceutical compositions containing the same. This invention highlights the development of oxadiazole compounds and their pharmaceutically acceptable salts, which are specifically designed for the treatment of neurological diseases such as epilepsy. Another notable patent is related to the use of a carbamate compound for the prevention, alleviation, or treatment of status epilepticus. This invention encapsulates a vital approach to managing this serious medical condition by administering a medicament comprising the designated carbamate compound.
Career Highlights
Yu Jin Shin is currently employed at Sk Biopharmaceuticals Co., Ltd., a prominent company dedicated to advancing therapeutic solutions. His dedication to research and innovation has positioned him as a key player in the pharmaceutical industry, particularly in tackling complex neurological disorders.
Collaborations
Throughout his career, Yu Jin Shin has collaborated with talented individuals in his field, including notable coworkers Choon Ho Ryu and Min Soo Han. These partnerships have not only enhanced the scope of research but have also fostered an environment of shared knowledge and innovation that drives the industry forward.
Conclusion
With five patents and a focus on neurological treatments, Yu Jin Shin continues to push the boundaries of medical innovation. His contributions at Sk Biopharmaceuticals Co., Ltd. and collaboration with fellow researchers exemplify the important role that inventors play in shaping the future of healthcare.